The IL-8-CXCR1/2 axis has been proposed as a potential therapeutic target for numerous cancers due to its contributing roles in proliferation, migration/invasion, angiogenesis, and tumor immunosuppression [61,62]. The gene discussed is CXCL8; the disease is neoplasm.